We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $820M
1-Year Est. Return 20.6%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+20.6%
3 Year Est. Return
+44.41%
5 Year Est. Return
+43.97%
10 Year Est. Return
–
AUM
$370M
AUM Growth
-$11.3M
Cap. Flow
-$7.72M
Cap. Flow %
-2.09%
Top 10 Hldgs %
66.71%
Holding
50
New
4
Increased
12
Reduced
21
Closed
4

Top Buys

Rank Stock Value
1
VGK icon
Vanguard FTSE Europe ETF
VGK
+$20.8M
2
IGHG icon
ProShares Investment Grade-Interest Rate Hedged
IGHG
+$873K
3
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$778K
4
CMCSA icon
Comcast
CMCSA
+$619K
5
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$501K

Top Sells

Rank Stock Value
1
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$6.67M
2
MGC icon
Vanguard Morningstar Mega Cap ETF
MGC
+$6.29M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$5M
4
MGV icon
Vanguard Morningstar Mega Cap Value ETF
MGV
+$4.88M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.78M

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.86%
2 Technology 4.59%
3 Communication Services 0.54%
4 Healthcare 0.51%
5 Energy 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPAC icon
26
iShares Core MSCI Pacific ETF
IPAC
$2.77B
$1.17M 0.32%
17,478
-416
-2% -$28K
INTC icon
27
Intel
INTC
$471B
$1.04M 0.28%
19,621
-543
-3% -$29.4K
CSCO icon
28
Cisco
CSCO
$433B
$1.03M 0.28%
18,874
+29
+0.2% +$1.63K
VUSB icon
29
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
$1.02M 0.28%
20,407
+8,909
+77% +$447K
PFE icon
30
Pfizer
PFE
$159B
$926K 0.25%
21,536
+45
+0.2% +$1.99K
MRK icon
31
Merck
MRK
$364B
$903K 0.24%
12,028
-1,660
-12% -$126K
T icon
32
AT&T
T
$177B
$714K 0.19%
34,980
+25
+0.1% +$525
VZ icon
33
Verizon
VZ
$208B
$679K 0.18%
12,575
-52
-0.4% -$2.88K
XOM icon
34
ExxonMobil
XOM
$641B
$675K 0.18%
11,471
-597
-5% -$34K
CMCSA icon
35
Comcast
CMCSA
$95.2B
$593K 0.16%
+10,610
New +$619K
BOX icon
36
Box
BOX
$4.88B
$340K 0.09%
14,357
-505
-3% -$12.4K
ATRS
37
DELISTED
Antares Pharma, Inc.
ATRS
$47K 0.01%
13,000
– –
SVRA icon
38
Savara
SVRA
$1.1B
$20K 0.01%
14,658
– –
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.08T
– –
-10,010
Closed -$2.78M
GE icon
40
GE Aerospace
GE
$355B
– –
-3,001
Closed -$201K
MDY icon
41
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
– –
-10,175
Closed -$5M
SNOW icon
42
Snowflake
SNOW
$114B
– –
-10,704
Closed -$2.59M
1
2

Similar funds

FA
Faithward Advisors Lancaster, Pennsylvania $819M AUM 41.44% 1-Year Est. Return
LFA
Legacy Financial Advisors Covington, Kentucky $820M AUM 31.98% 1-Year Est. Return
CCM
Canal Capital Management Richmond, Virginia $819M AUM 24.27% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
LSIA
LaSalle St. Investment Advisors Elmhurst, Illinois $818M AUM 23.46% 1-Year Est. Return
GSWM
Greenup Street Wealth Management Ann Arbor, Michigan $822M AUM 25.64% 1-Year Est. Return
DA
Dillon & Associates Jackson, Michigan $817M AUM 22.58% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return

Capital Advantage's Q3 2021 Portfolio in Review

As of Q3 2021, Capital Advantage held 50 positions worth $370M, down 3% from $381M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Capital Advantage's Q3 2021 filing shows 4 new, 12 increased, 21 reduced and 4 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 303,846 shares worth $19.9M. The largest sale was Vanguard Dividend Appreciation ETF, an estimated $6.67M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Communication Services.

  • Capital Advantage's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 303,846 shares worth $19.9M.
  • Capital Advantage added most to ProShares Investment Grade-Interest Rate Hedged in Q3 2021, an estimated $873K increase.
  • Capital Advantage's biggest Q3 2021 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $6.67M.
  • Capital Advantage fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2021, selling an estimated $5M.
  • Capital Advantage's ten largest holdings make up 67% of its $370M portfolio in Q3 2021.
  • Capital Advantage opened 4 new positions and closed 4 in Q3 2021.
  • Capital Advantage's portfolio value fell 3% quarter-over-quarter to $370M.

Based on Capital Advantage's 13F filing for Q3 2021, filed 7 Oct 2021.